世界中医药
文章摘要
引用本文:胡义扬.中医药治疗非酒精性脂肪性肝病的优势与展望[J].世界中医药,2015,10(02):.  
中医药治疗非酒精性脂肪性肝病的优势与展望
Advantages and Prospects of Traditional Chinese Medicine in Treating Nonalcoholic fatty liver disease
投稿时间:2014-12-26  
DOI:10.3969/j.issn.1673-7202.2015.02.001
中文关键词:  非酒精性脂肪性肝病,中医药  优势  展望
English Keywords:Nonalcoholic Fatty Liver Disease, Traditional Chinese Medicine, Advantages, Prospect
基金项目:国家自然基金面上项目(编号:81374031,81173404)
作者单位
胡义扬 上海中医药大学附属曙光医院上海中医药大学肝病研究所上海高校中医内科学E-研究院教育部肝肾疾病病证实验室上海市中医临床重点实验室上海201203 
摘要点击次数: 1006
全文下载次数: 1573
中文摘要:
      目前非酒精性脂肪性肝病的西医治疗手段与不断升高的发病率呈不相吻合的趋势。在临床治疗中,中医药占重要一席之地。作者认为,中医药治疗非酒精性脂肪性肝病的主要优势点在于:1)临床运用广泛且具疗效;2)中药多途径的治疗效应与疾病的复杂机理相对应;3)抑制炎症、保肝降酶效应显著。并在如何开展临床研究;从调节肠道菌群、抗肝纤维化、以及中药组分复方方面开展基础研究提出了设想和展望。
English Summary:
      Currently, there is a mismatch between the limited treatments of western medicine and the rising incidence rate of nonalcoholic fatty liver disease(NAFLD). Traditional Chinese Medicine(TCM) is now playing an important role in the clinical treatment of liver diseases including NAFLD. In this article, we review the main advantages of TCM in treating NAFLD as follows:1)TCM is widespread used and shown the efficacy in clinic;2)The multi-path effect of TCM corresponds to the complicated pathogenesis of diseases;3)TCM has remarkable effect in inhibition of inflammation as well as in reducing enzymes and protecting liver. We also put forward suggestion and prospects in both clinical and basic research on regulating intestinal flora, anti-fibrosis and the compound prescription of TCM.
查看全文  查看/发表评论  下载PDF阅读器